Peroxisome proliferator-activated receptor-α contributes to the resolution of inflammation after renal ischemia/reperfusion injury

Journal of Pharmacology and Experimental Therapeutics

Volumn 328, Issue 2, 2009, Pages 635-643

  Patel, Nimesh S A ^a   Di Paola, Rosanna ^b,c   Mazzon, Emanuela ^b,c   Britti, Domenico ^d   Thiemermann, Christoph ^a   Cuzzocrea, Salvatore ^b,c  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF MESSINA   (Italy)

^c IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^d UNIVERSITY OF TERAMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATININE; FENOFIBRATE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GENE DELETION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DISEASE; KIDNEY DYSFUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; MALE; MOUSE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; UREA BLOOD LEVEL;

ANIMALS; DISEASE MODELS, ANIMAL; INFLAMMATION; KIDNEY DISEASES; MALE; MICE; PPAR ALPHA; REPERFUSION INJURY;

EID: 59649087465     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.108.146191     Document Type: Article

References (44)

1. Alonzi T, Fattori E, Cappelletti M, Ciliberto G, and Poli V (1998) Impaired Stat3 activation following localized inflammatory stimulus in IL-6-deficient mice. Cytokine 10:13-18.
2. Beckman JS, Beckman TW, Chen J, Marshall PA, and Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87:1620-1624.
3. Caramelo C and Alvarez Arroyo MV (1998) Polymorphonuclear neutrophils in acute renal failure: new insights. Nephrol Dial Transplant 13:2185-2188.
4. Chatterjee PK, Cuzzocrea S, Brown PA, Zacharowski K, Stewart KN, Mota-Filipe H, and Thiemermann C (2000a) Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat. Kidney Int 58:658-673.
5. Chatterjee PK, Patel NS, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, Britti D, Eberhardt W, Pfeilschifter J, and Thiemermann C (2004) The cyclopentenone prostaglandin 15-deoxy-delta(12,14)-prostaglandin J2 ameliorates ischemic acute renal failure. Cardiovasc Res 61:630-643.
6. Chatterjee PK, Patel NS, Sivarajah A, Kvale EO, Dugo L, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, Britti D, et al. (2003) GW274150, a potent and highly selective inhibitor of iNOS, reduces experimental renal ischemia/reperfusion injury. Kidney Int 63:853-865.
7. Chatterjee PK and Thiemermann C (2003) An in vivo model of ischemia/reperfusion and inflammation of the kidneys of the rat. Methods Mol Biol 225:223-237.
8. Chatterjee PK, Zacharowski K, Cuzzocrea S, Otto M, and Thiemermann C (2000b) Inhibitors of poly (ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo. FASEB J 14:641-651.
9. Cockerill GW, McDonald MC, Mota-Filipe H, Cuzzocrea S, Miller NE, and Thiemermann C (2001) High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock. FASEB J 15:1941-1952.
10. Collino M, Patel NS, Lawrence KM, Collin M, Latchman DS, Yaqoob MM, and Thiemermann C (2005) The selective PPARgamma antagonist GW9662 reverses the protection of LPS in a model of renal ischemia-reperfusion. Kidney Int 68:529-536.
11. Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muià C, and Caputi AP (2004a) WY 14643, a potent exogenous PPAR-alpha ligand, reduces intestinal injury associated with splanchnic artery occlusion shock. Shock 22:340-346.
12. Cuzzocrea S, Di Paola R, Mazzon E, Genovese T, Muià C, Centorrino T, and Caputi AP (2004b) Role of endogenous and exogenous ligands for the peroxisome proliferators activated receptors alpha (PPAR-alpha) in the development of inflammatory bowel disease in mice. Lab Invest 84:1643-1654.
13. Delerive P, De Bosscher K, Vanden Berghe W, Fruchart JC, Haegeman G, and Staels B (2002) DNA binding-independent induction of ikappabalpha gene transcription by PPARalpha. Mol Endocrinol 16:1029-1039.
14. Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, and Wahli W (1996) The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 384:39-43.
15. Dewald O, Sharma S, Adrogue J, Salazar R, Duerr GD, Crapo JD, Entman ML, and Taegtmeyer H (2005) Downregulation of peroxisome proliferator-activated receptor-alpha gene expression in a mouse model of ischemic cardiomyopathy is dependent on reactive oxygen species and prevents lipotoxicity. Circulation 112:407-415.
16. Dragun D, Hoff U, Park JK, Qun Y, Schneider W, Luft FC, and Haller H (2000) Ischemia-reperfusion injury in renal transplantation is independent of the immunologic background. Kidney Int 58:2166-2177.
17. Duhaney TA, Cui L, Rude MK, Lebrasseur NK, Ngoy S, De Silva DS, Siwik DA, Liao R, and Sam F (2007) Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload. Hypertension 49:1084-1094.
18. Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, and van der Vliet A (1998) Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391:393-397.
19. Evans RM (1988) The steroid and thyroid hormone receptor superfamily. Science 240:889-895.
20. Genovese T, Mazzon E, Di Paola R, Cannavò G, Muià C, Bramanti P, and Cuzzocrea S (2005) Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord trauma. Exp Neurol 194:267-278.
21. Gervois P, Vu-Dac N, Kleemann R, Kockx M, Dubois G, Laine B, Kosykh V, Fruchart JC, Kooistra T, and Staels B (2001) Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta. J Biol Chem 276:33471-33477.
22. Greene ME, Blumberg B, McBride OW, Yi HF, Kronquist K, Kwan K, Hsieh L, Greene G, and Nimer SD (1995) Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr 4:281-299.
23. Guan Y, Zhang Y, Davis L, and Breyer MD (1997) Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans. Am J Physiol 273:F1013-F1022.
24. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals, 7th ed, Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
25. Letavernier E, Perez J, Joye E, Bellocq A, Fouqueray B, Haymann JP, Heudes D, Wahli W, Desvergne B, and Baud L (2005) Peroxisome proliferator-activated receptor beta/delta exerts a strong protection from ischemic acute renal failure. J Am Soc Nephrol 16:2395-2402.
26. Lovett-Racke AE, Hussain RZ, Northrop S, Choy J, Rocchini A, Matthes L, Chavis JA, Diab A, Drew PD, and Racke MK (2004) Peroxisome proliferator- activated receptor alpha agonists as therapy for autoimmune disease. J Immunol 172:5790-5798.
27. Moraes LA, Piqueras L, and Bishop-Bailey D (2006) Peroxisome proliferator-activated receptors and inflammation. Pharmacol Ther 110:371-385.
28. Moras D and Gronemeyer H (1998) The nuclear receptor ligand-binding domain: structure and function. Curr Opin Cell Biol 10:384-391.
29. Ouali F, Djouadi F, Merlet-Bénichou C, and Bastin J (1998) Dietary lipids regulate beta-oxidation enzyme gene expression in the developing rat kidney. Am J Physiol 275:F777-F784.
30. Paller MS (1994a) The cell biology of reperfusion injury in the kidney. J Investig Med 42:632-639.
31. Paller MS (1994b) Pathophysiologic Mechanisms of Acute Renal Failure, CRC Press, Ann Arbor, MI.
32. Park CW, Kim HW, Ko SH, Chung HW, Lim SW, Yang CW, Chang YS, Sugawara A, Guan Y, and Breyer MD (2006) Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha. Diabetes 55:885-893.
33. Patel NS, Chatterjee PK, Di Paola R, Mazzon E, Britti D, De Sarro A, Cuzzocrea S, and Thiemermann C (2005a) Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion. J Pharmacol Exp Ther 312:1170-1178.
34. Patel NS, Cortes U, Di Poala R, Mazzon E, Mota-Filipe H, Cuzzocrea S, Wang ZQ, and Thiemermann C (2005b) Mice lacking the 110-kD isoform of poly(ADP-ribose) glycohydrolase are protected against renal ischemia/reperfusion injury. J Am Soc Nephrol 16:712-719.
35. Portilla D, Dai G, Peters JM, Gonzalez FJ, Crew MD, and Proia AD (2000) Etomoxir-induced PPARalpha-modulated enzymes protect during acute renal failure. Am J Physiol Renal Physiol 278:F667-F675.
36. Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, Barnes S, Kirk M, and Freeman BA (1994) Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation: formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 269:26066-26075.
37. Sheridan AM and Bonventre JV (2001) Pathophysiology of ischemic acute renal failure. Contrib Nephrol 132:7-21.
38. Sivarajah A, Chatterjee PK, Hattori Y, Brown PA, Stewart KN, Todorovic Z, Mota-Filipe H, and Thiemermann C (2002) Agonists of peroxisome-proliferator activated receptor-alpha (clofibrate and WY14643) reduce renal ischemia/reperfusion injury in the rat. Med Sci Monit 8:BR532-BR539.
39. Sivarajah A, Chatterjee PK, Patel NS, Todorovic Z, Hattori Y, Brown PA, Stewart KN, Mota-Filipe H, Cuzzocrea S, and Thiemermann C (2003) Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia/reperfusion injury. Am J Nephrol 23:267-276.
40. Staels B, Koenig W, Habib A, Merval R, Lebret M, Torra IP, Delerive P, Fadel A, Chinetti G, Fruchart JC, et al. (1998) Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators. Nature 393:790-793.
41. Szabó C, Lim LH, Cuzzocrea S, Getting SJ, Zingarelli B, Flower RJ, Salzman AL, and Perretti M (1997) Inhibition of poly (ADP-ribose) synthetase attenuates neutrophil recruitment and exerts antiinflammatory effects. J Exp Med 186:1041-1049.
42. Thiemermann C, Patel NS, Kvale EO, Cockerill GW, Brown PA, Stewart KN, Cuzzocrea S, Britti D, Mota-Filipe H, and Chatterjee PK (2003) High density lipoprotein (HDL) reduces renal ischemia/reperfusion injury. J Am Soc Nephrol 14:1833-1843.
43. Utsunomiya I, Nagai S, and Oh-ishi S (1991) Sequential appearance of IL-1 and IL-6 activities in rat carrageenin-induced pleurisy. J Immunol 147:1803-1809.
44. Ysebaert DK, De Greef KE, Vercauteren SR, Ghielli M, Verpooten GA, Eyskens EJ, and De Broe ME (2000) Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 15:1562-1574.